Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Mario Delia

University of Bari Aldo Moro

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Virology

30%

Hematology

90%

Graft-versus-host Disease

40%

Fungal Pathology

20%

Targeted Therapy

20%

Regulatory T Cells

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Total body irradiation-based myeloablative conditioning for acute lymphoblastic leukaemia patients undergoing allogeneic haematopoietic stem cell transplantation: the best way to prevent relapse in a real-world scenario

Article Link

Year:

2025

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience

Article Link

Year:

2023

Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience

Article Link

Year:

2023

Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation

Article Link

Year:

2022

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study

Article Link

Year:

2022

When Viruses Meet Fungi: Tackling the Enemies in Hematology

Article Link

Year:

2022

Long-Term Follow-Up of Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine: A Real-World Study of the Apulian Hematological Network

Article Link

Year:

2022

Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients

Article Link

Year:

2022

The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Article Link

Year:

2021

What Is New in the Treatment of Smoldering Multiple Myeloma?

Article Link

Year:

2021

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study

Article Link

Year:

2020

Collaborators7

Francesca Farina

IRCCS San Raffaele Scientific Institute

ITALY

Fabio Guolo

University of Genova

ITALY

Livio PAGANO

Prof associato di Ematologia

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

Niccolò Bolli

University of Milan

ITALY

maria ilaria del principe

UNIVERSITY TOR VERGATA

ITALY

Patrizia Chiusolo

ITALY

Daniele Zama

University of Bologna

ITALY

How do I reach out?

Meet Kite AI